Biocon shares may witness some action after the pharma company expanded its generic formulations portfolio, with the launch of tacrolimus capsules in the United States.
from NDTV Profit - Latest https://ift.tt/2WOzU74
via
This blog is all about making you come close to your success. All about how people tasted success. Learn and Lead.
Subscribe to:
Post Comments (Atom)
-
Coal accounts for over 70 per cent of the country's electricity output, and utilities account for about 75 per cent of India's coal ...
-
Cryptocurrency Bitcoin is witnessing a boom and the coin managed to gain 2.19 per cent and traded at $30,543.48 on Monday. The value of the ...
-
World gross product growth is now expected to moderate from 3.0 per cent in 2018 to 2.7 per cent in 2019 and 2.9 per cent in 2020 from NDT...
No comments:
Post a Comment